Literature DB >> 6140077

Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.

S Ramakrishnan, L L Houston.   

Abstract

Ricin A chain and pokeweed antiviral protein (PAP), two enzymes that inhibit the action of eukaryotic ribosomes, were coupled by cleavable, N-succinimidyl-3-(2-pyridyldithio)propionate, and noncleavable m-maleimidobenzoyl-N-hydroxysuccinimide ester, cross-linking reagents to monoclonal antibodies directed against Thy 1.1 antigen. Leukemia cells that contained Thy 1.1 antigen were selectively killed compared to Thy 1.2-containing cells. The composition of the conjugates was determined by radioimmunoassay, and most of the immunotoxins contained about equal molar quantities of antibody and ribosomal inhibitor. Ricin A chain linked to antibody by a noncleavable m-maleimidobenzoyl-N-hydroxysuccinimide ester cross-link was not cytotoxic, but PAP coupled to the same antibody was. Both immunotoxins linked by a cleavable disulfide bond were cytotoxic. Disulfide-linked F(ab')2-PAP was cytotoxic, but it was about 45 times less efficient than disulfide-linked IgG-PAP. There was only a 3.2-fold difference in their ability to inhibit ribosomes in vitro. The relative difference between in vitro action and cytotoxicity could be accounted for by differences in the affinity of the immunotoxins to the cell surface. Neither PAP or ricin A chain disulfide linked to a monoclonal antibody against Mr 15,000 envelope protein, a murine leukemia virus coat protein, were not cytotoxic, although both conjugates bound to the cell surface. Because of its stability, ease of purification, and lack of an analogue of ricin B chain, PAP may be more useful than ricin A for immunotoxin synthesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140077

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  The in-vitro inhibition of rat alloantigen presentation by immunotoxins--implications for allografting.

Authors:  K N Wiley; A Clark; M Fox
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity.

Authors:  Xing Du; Richard Beers; David J Fitzgerald; Ira Pastan
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Peptides and proteins as drugs.

Authors:  B L Ferraiolo; L Z Benet
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

Review 4.  Immunotoxins against solid tumors.

Authors:  R Pirker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Effects of thiolation on the immunoreactivity of the ribosome-inactivating protein gelonin.

Authors:  V Singh; M R Sairam
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

6.  An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.

Authors:  P L Tazzari; L Barbieri; M Gobbi; A Dinota; S Rizzi; A Bontadini; A Pession; S Tura; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Monoclonal anti-human T cell antibody and PAP-s conjugate--preparation and selective cytotoxic properties on leukemic cell.

Authors:  J Y Chu; A D Yang; B M Wang; Z Hu; X M Zhu; H J Zhang; J H Qu; L Y Luo; R Guo; L R Shi
Journal:  J Tongji Med Univ       Date:  1990

8.  Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.

Authors:  T Kikuchi; T Ohnuma; J F Holland; L E Spitler
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Ex vivo elimination of neoplastic T-cells from human marrow using an anti-Mr 41,000 protein immunotoxin: potentiation by ASTA Z 7557.

Authors:  F M Uckun; S Ramakrishnan; L L Houston
Journal:  Blut       Date:  1985-01

10.  Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiator.

Authors:  D M Fishwild; M O Staskawicz; H M Wu; S F Carroli
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.